Skip to main content

Stocks in play: CareRx Corporation

Baystreet.ca - Baystreet - Wed Mar 5, 2025

Today reported its financial results for the fourth quarter ended December 31, 2024. Revenue for the quarter was $92.2 million as compared to $92.8 million for the third quarter of 2024 and $91.1 million for the fourth quarter of 2023. Adjusted EBITDA for the quarter was $7.6 million as compared to $7.8 million for the third quarter of 2024 and $7.5 million for the fourth quarter of 2023: CareRx Corporation shares T.CRRX are trading down $0.16 at $2.50.

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).